Key terms

About CAH

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CAH news

Feb 28 4:44pm ET Cardinal Health Welcomes Robert Azelby to Board of Directors Feb 26 8:10am ET Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE) Feb 26 6:19am ET Cardinal Health initiated with an Outperform at Leerink Feb 20 4:48pm ET Cardinal Health Issues $1.15 Billion Notes for Long-Term Growth Feb 14 10:01am ET FTC probing drug distributors over low supplies of chemotherapies, WSJ reports Feb 09 9:41am ET PayPal downgraded, United Airlines upgraded: Wall Street’s top analyst calls Feb 09 8:29am ET Argus upgrades Cardinal Health to Buy on COVID-19 vaccine, generics demand Feb 09 7:24am ET Cardinal Health upgraded to Buy from Hold at Argus Feb 08 7:17am ET Neurocrine price target raised to $154 from $150 at Canaccord Feb 06 10:01am ET Precipio, Cardinal Health enter distribution agreement for HemeScreen portfolio Feb 06 5:37am ET Maintaining Sell Rating on Cardinal Health Amid Temporary Gains and Segment Underperformance Feb 05 7:52am ET Cardinal Health price target raised to $125 from $122 at UBS Feb 05 4:20am ET Maintaining Hold on Cardinal Health: A Balanced View of Cash Flow Growth and Valuation Concerns Feb 02 7:40am ET Cardinal Health price target raised to $109 from $96 at TD Cowen Feb 02 7:04am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Cardinal Health (CAH) Feb 02 6:45am ET Cardinal Health price target raised to $133 from $128 at Baird Feb 02 3:37am ET Barclays Reaffirms Their Buy Rating on Cardinal Health (CAH) Feb 01 9:25pm ET Cardinal Health price target raised to $115 from $112 at BofA Feb 01 8:25pm ET Cardinal Health: A Hold Rating with a Cautious Yet Steady Outlook Feb 01 8:16pm ET Cardinal Health: Hold Rating with Revised Price Objective Amid Mixed Segment Performance and Execution Risks Feb 01 7:01am ET Cardinal Health raises FY24 EPS view to $7.20 to $7.35 from $6.75-$7.00 Feb 01 6:59am ET Cardinal Health reports Q2 EPS $1.82, consensus $1.60 Jan 31 8:25pm ET Notable companies reporting before tomorrow’s open Jan 31 12:59pm ET Notable companies reporting before tomorrow’s open Jan 31 10:43am ET M & A News: Cardinal Health (NYSE:CAH) Jumps on $1.2B Acquisition of Specialty Networks Jan 31 9:20am ET Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Novo Nordisk (NVO) and Boston Scientific (BSX) Jan 31 7:06am ET Cardinal Health to acquire Specialty Networks for $1.2B in cash Jan 24 6:59am ET Cardinal Health price target raised to $117 from $112 at JPMorgan Jan 10 7:21am ET Analysts Conflicted on These Healthcare Names: Korro Bio (KRRO), Intuitive Surgical (ISRG) and Cardinal Health (CAH) Jan 10 6:47am ET Cardinal Health price target raised to $128 from $126 at Baird Jan 09 6:52am ET Cardinal Health affirms long-term financial targets

No recent news articles are available for CAH

No recent press releases are available for CAH

CAH Financials

1-year income & revenue

Key terms

CAH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CAH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms